Skip to main content
. 2023 Apr 5;13(9):2315–2339. doi: 10.1007/s13346-023-01315-w

Table 7.

Effect of VA on serum CK-MB activity and cardiac MDA and GSH contents

Normal MI control VA VA formulation
CK-MB (U/L) 111.0 ± 2.3 711.0a ± 58.3 466.5ab ± 25.1 244.0bc ± 56.8
MDA (nmol/g) 35.81 ± 1.2 62.04a ± 3.5 47.93ab ± 3.7 33.61bc ± 2.9
GSH (μmol/g) 3.59 ± 0.3 2.15a ± 0.1 3.90ab ± 0.4 7.05bc ± 0.3

The data is presented as mean ± SEM (n = 6)

asignificant difference from normal group

bsignificant difference from MI control group

csignificant difference from VA group (at p < 0.05)